Back to Search
JEFFREY HALLER MD
MD
Otolaryngology Physician
NPI: 1194712307IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
9810(MT)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission.
PMID 19421027·Behav Pharmacol·2009
7-preclinical
Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.
PMID 18248928·Eur J Radiol·2009
8-other
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
PMID 19268890·Am J Ophthalmol·2009
4-observational
Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions.
PMID 19415286·Eur Radiol·2009
8-other
Validity of the Omron HJ-112 pedometer during treadmill walking.
PMID 19276853·Med Sci Sports Exerc·2009
4-observational
Development and use of a selectable, broad-host-range reporter transposon for identifying environmentally regulated promoters in bacteria.
PMID 19146571·FEMS Microbiol Lett·2009
8-other
Octylglucopyranoside and cyclodextrin in water. Self-aggregation and complex formation.
PMID 19170546·J Phys Chem B·2009
8-other
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
PMID 19259645·Psychopharmacology (Berl)·2009
4-observational
Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain.
PMID 19303746·Eur Neuropsychopharmacol·2009
7-preclinical
Substance P neurotransmission and violent aggression: the role of tachykinin NK(1) receptors in the hypothalamic attack area.
PMID 19344710·Eur J Pharmacol·2009
7-preclinical
Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema.
PMID 18827732·Retina·2009
4-observational
Risk factors for rhegmatogenous retinal detachment in the submacular surgery trials: SST report No. 22.
PMID 19516120·Retina·2009
2-rct
In vivo investigation of breast cancer progression by use of an internal control.
PMID 19242603·Neoplasia·2009
7-preclinical
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.
PMID 19174400·Br J Ophthalmol·2009
3-trial
The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
PMID 18054070·Front Neuroendocrinol·2008
6-review
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.
PMID 18054887·Am J Ophthalmol·2008
5-case
Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment.
PMID 18779499·Arch Ophthalmol·2008
5-case
Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging.
PMID 18202169·J Appl Physiol (1985)·2008
7-preclinical
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
PMID 17904589·Neuropharmacology·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 700 W KENT AVE
MISSOULA, MT 59801 - Phone
- (406) 541-3277
Quick Facts
- NPI
- 1194712307
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile